s6y
Company name or ticker
Search
Obsidian Therapeutics, Inc.
4
Reisenauer Mark L: Statement of changes in beneficial ownership of securities
Filed
Friday, November 13, 2026
Period
Nov 10, 2026
Accession number
0001104659-26-127203
Documents
OWNERSHIP DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header